Jan 30, 2026 04:15PM
Jan 30, 2026 04:15PM
Dec 8, 2025 08:32AM
Dec 8, 2025 08:30AM
Dec 4, 2025 08:32AM
Dec 4, 2025 08:30AM
Dec 1, 2025 08:30AM Galmed CEO outlines drug development plans in shareholder letter
Dec 1, 2025 08:30AM
Nov 26, 2025 08:30AM
Nov 18, 2025 08:30AM
Nov 17, 2025 08:31AM
Nov 17, 2025 08:30AM
Aug 28, 2025 08:00AM
Aug 25, 2025 07:31AM Galmed plans to invest up to $10 million in digital assets
Aug 25, 2025 07:30AM
May 27, 2025 08:00AM
May 22, 2025 08:00AM
May 13, 2025 08:00AM
May 6, 2025 07:30AM
Apr 28, 2025 08:00AM
Apr 17, 2025 08:30AM Galmed Pharmaceuticals Launches VCU Collaboration to Tackle Drug Resistance in GI Cancers
Apr 15, 2025 08:32AM
Apr 15, 2025 08:30AM
Apr 10, 2025 08:00AM
Apr 2, 2025 04:10PM
Sep 25, 2024 08:01AM
Sep 25, 2024 08:00AM
Sep 20, 2024 09:00AM How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
Sep 19, 2024 07:06AM
Sep 19, 2024 07:00AM
Apr 4, 2024 05:06PM
Mar 15, 2024 09:01AM
Mar 15, 2024 09:00AM
Nov 20, 2023 04:34PM
Nov 20, 2023 04:32PM Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
Sep 26, 2023 08:30AM
Sep 22, 2023 04:08PM
Sep 22, 2023 04:05PM
Jul 14, 2023 09:31AM
Jul 14, 2023 09:30AM
Jul 10, 2023 08:00AM
Jun 1, 2023 08:00AM Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Developments
May 9, 2023 07:00AM
Mar 29, 2023 05:00PM
Feb 8, 2023 08:04AM
Feb 8, 2023 08:00AM
Jan 4, 2023 08:12AM
Jan 4, 2023 08:00AM
Dec 14, 2022 05:03PM Galmed Pharma (GLMD) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement
Dec 14, 2022 05:00PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All